News and Announcements
SUDA Ltd Annual Update 2015; Advances Pipeline & Begins Deal Negotiations
- Published December 16, 2015 10:32AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
SUDA LTD has advanced its pipeline of OroMist® oral sprays in 2015 including finalising the design of pivotal trials for two of its lead products and a successful meeting with FDA. The Company has made significant progress towards its business development goals to out-license its products to the pharmaceutical companies across the world.
Discussions with prospective partners span SUDA’s novel sublingual antimalarial spray, ArTiMist™, and its oral sprays for insomnia, migraine, nausea, and erectile dysfunction, as well as the application of SUDA’s OroMist® technology to new compounds. Discussions are at various stages with some companies having completed due diligence and initiated deal negotiations.
The Company’s operations have expanded in 2015 with the addition of new staff as well as the formation of SUDA Europe in London, UK, to widen its business development footprint and provide access to further grant funding and the UK patent box.
SUDA anticipates that 2016 will be an exciting year for the Company with the prospect of securing several commercial deals, creating significant shareholder value.
ABOUT SUDA
SUDA Ltd (ASX: SUD) is a drug delivery company focused on oro-mucosal administration, headquartered in Perth, WA. The Company is developing low-risk oral sprays using novel formulations of existing pharmaceuticals. The many potential benefits of administering drugs through the oral mucosa (ie: cheeks, tongue, gums) include ease of use, lower dosage, reduced side effects and faster response time.
SUDA’s product pipeline includes first-in-class oral sprays for insomnia, malaria, migraine, nausea and vomiting, erectile dysfunction and pre-procedural anxiety.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
